A Perfect Match: CEO Successfully Navigates Early-Stage Investment

22 Apr

By Rory McCann, Marketing Manager & Conference Producer, LSN

APIE Therapeutics is an early-stage company developing vascular endothelium niche repair and regeneration. We spoke with CEO, Dr. Esther Alegría about the early days of APIE Therapeutics and the importance of fit when seeking capital and building a powerful team.

APIE Therapeutics is an Innovator’s Pitch Challenge winner at last month’s Longevity, Health & Innovation, a Redefining Early Stage Investments (RESI) partnering event. Learn more about RESI and sign up by May 7 to save $50 on early bird rates.

RESI Longevity, September 16-17, is now accepting Innovator’s Pitch Challenge applications. Learn more and sign up by July 23 to save!

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: